Germany
Japan
United Kingdom
China
USD 1,020.00
6 Weeks
Lenti ORF particles, GHR (Myc-DDK-tagged)-Human growth hormone receptor (GHR), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
cDNA Clones
Lenti ORF particles, ASCL4 (Myc-DDK-tagged)-Human achaete-scute complex homolog 4 (Drosophila) (ASCL4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, IL1RL2 (Myc-DDK tagged) - Human interleukin 1 receptor-like 2 (IL1RL2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, MUC4 (Myc-DDK-tagged)-Human mucin 4, cell surface associated (MUC4), transcript variant 5, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, POLD3 (Myc-DDK tagged) - Human polymerase (DNA-directed), delta 3, accessory subunit (POLD3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,176.00
6 Weeks
Lenti ORF particles, TGFBR2 (Myc-DDK tagged) - Human transforming growth factor, beta receptor II (70/80kDa) (TGFBR2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TMEM158 (Myc-DDK tagged) - Human transmembrane protein 158 (gene/pseudogene) (TMEM158), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SMAD9 (Myc-DDK-tagged)-Human SMAD family member 9 (SMAD9), transcript variant a, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CHRDL1 (Myc-DDK-tagged)-Human chordin-like 1 (CHRDL1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, NUDT16 (Myc-DDK-tagged)-Human nudix (nucleoside diphosphate linked moiety X)-type motif 16 (NUDT16), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,164.00
6 Weeks
Lenti ORF particles, PPP1R12B (Myc-DDK-tagged)-Human protein phosphatase 1, regulatory (inhibitor) subunit 12B (PPP1R12B), transcript variant 5, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, BACH2 (Myc-DDK-tagged)-Human BTB and CNC homology 1, basic leucine zipper transcription factor 2 (BACH2), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, MCL1 (Myc-DDK-tagged)-Human myeloid cell leukemia sequence 1 (BCL2-related) (MCL1), nuclear gene encoding mitochondrial protein, transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, Adam9 (Myc-DDK-tagged ORF) - Rat ADAM metallopeptidase domain 9 (meltrin gamma) (Adam9), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, Tfeb (Myc-DDK-tagged ORF) - Rat transcription factor EB (Tfeb), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, Pf4 (Myc-DDK-tagged) - Mouse platelet factor 4 (Pf4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, Sertad1 (Myc-DDK-tagged) - Mouse SERTA domain containing 1 (Sertad1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, Gpr137b (Myc-DDK-tagged) - Mouse G protein-coupled receptor 137B (Gpr137b), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, Il11ra1 (Myc-DDK-tagged) - Mouse interleukin 11 receptor, alpha chain 1 (Il11ra1), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, Csf1 (Myc-DDK-tagged) - Mouse colony stimulating factor 1 (macrophage) (Csf1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles of Hsd17b2 (Myc-DDK-tagged) - Mouse hydroxysteroid (17-beta) dehydrogenase 2 (Hsd17b2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, IFNGR2 (Myc-DDK tagged) - Human interferon gamma receptor 2 (interferon gamma transducer 1) (IFNGR2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PKM (Myc-DDK-tagged)-Human pyruvate kinase, muscle (PKM2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, VSIG4 (Myc-DDK tagged) - Human V-set and immunoglobulin domain containing 4 (VSIG4), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, GPT (Myc-DDK tagged) - Human glutamic-pyruvate transaminase (alanine aminotransferase) (GPT), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TIMD4 (Myc-DDK tagged) - Human T-cell immunoglobulin and mucin domain containing 4 (TIMD4), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
5 Weeks
Lenti ORF particles, ALPPL2 (Myc-DDK tagged) - Human alkaline phosphatase, placental-like 2 (ALPPL2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, HSPA5 (Myc-DDK tagged) - Human heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) (HSPA5), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SNX10 (Myc-DDK tagged) - Human sorting nexin 10 (SNX10), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, AXL (Myc-DDK tagged) - Human AXL receptor tyrosine kinase (AXL), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
7 Weeks
Lenti ORF particles, PKLR (Myc-DDK tagged) - Human pyruvate kinase, liver and RBC (PKLR), nuclear gene encoding mitochondrial protein, transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, GP2 (Myc-DDK tagged) - Human glycoprotein 2 (zymogen granule membrane) (GP2), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SFPQ (Myc-DDK-tagged)-Human splicing factor proline/glutamine-rich (SFPQ), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,000.00
3 Weeks
Lenti ORF particles, ERBB3 (Myc-DDK tagged) - Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (ERBB3), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
5 Weeks
Lenti ORF particles, CADM1 (Myc-DDK tagged) - Human cell adhesion molecule 1 (CADM1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, BRD4 (Myc-DDK tagged) - Human bromodomain containing 4 (BRD4), transcript variant short, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, HAVCR1 (Myc-DDK tagged) - Human hepatitis A virus cellular receptor 1 (HAVCR1), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TRPV1 (Myc-DDK tagged) - Human transient receptor potential cation channel, subfamily V, member 1 (TRPV1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SFTA2 (Myc-DDK tagged) - Human surfactant associated 2 (SFTA2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 830.00
5 Weeks
Lenti ORF particles, CHKA (Myc-DDK tagged) - Human choline kinase alpha (CHKA), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
5 Weeks
Lenti ORF particles, UPK2 (Myc-DDK tagged) - Human uroplakin 2 (UPK2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, TNFSF4 (Myc-DDK tagged) - Human tumor necrosis factor (ligand) superfamily, member 4 (TNFSF4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
5 Weeks
Lenti ORF particles, ACOD1 (Myc-DDK tagged) - Human aconitate decarboxylase 1 (ACOD1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, KDM5C (Myc-DDK-tagged)-Human lysine (K)-specific demethylase 5C (KDM5C), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Active filters
Lentivirus
- Particles
Tags
- Myc-DDK
Vectors
- pLenti-C-Myc-DDK-P2A-Puro
Brands
- LentiORF
Filter by
Target Symbol
- H2 (38)
- CREM (31)
- VEGFA (27)
- DISC1 (26)
- MORF4L2 (24)
- HMGA1 (23)
- PDE9A (23)
- ASPH (22)
- TPM1 (21)
- BDNF (20)
- MBP (20)
- NRG1 (20)
- CTNND1 (19)
- DTNA (19)
- OPRM1 (19)
- ABI1 (18)
- FGFR2 (18)
- KCNQ2 (18)
- SYBU (18)
- TCF7L2 (18)
- NR1I3 (17)
- PROM1 (17)
- ARPP21 (15)
- ATXN3 (15)
- FGFR1 (15)
- GNAS (15)
- NREP (15)
- PARD3 (15)
- PDE4D (15)
- ABLIM2 (14)
- ADGRG2 (14)
- CAMK2B (14)
- CD46 (14)
- CEACAM1 (14)
- CELF2 (14)
- DAG1 (14)
- DMD (14)
- EDA (14)
- EIF5A (14)
- FHL1 (14)
- GPM6B (14)
- HNRNPF (14)
- MEIS2 (14)
- PDLIM5 (14)
- SEPT9 (14)
- SMOX (14)
- SYTL2 (14)
- TGIF1 (14)
- TNNT2 (14)
- APTX (13)
- BIN1 (13)
- CD1E (13)
- DMKN (13)
- IGF1 (13)
- KCNIP2 (13)
- LDB3 (13)
- MADD (13)
- MIER1 (13)
- NCALD (13)
- NRP2 (13)
- ODF2 (13)
- OXR1 (13)
- PLEKHB1 (13)
- RBFOX2 (13)
- SORBS1 (13)
- ST3GAL3 (13)
- STAU2 (13)
- STRA6 (13)
- TFDP2 (13)
- TNNT3 (13)
- CD44 (12)
- CNOT4 (12)
- DCLK1 (12)
- ENSA (12)
- FXYD3 (12)
- HNRNPD (12)
- IKBKG (12)
- ISLR2 (12)
- MEN1 (12)
- NEDD4L (12)
- NF2 (12)
- OSBPL9 (12)
- PAK3 (12)
- PCBP2 (12)
- PDE1C (12)
- PPHLN1 (12)
- PREPL (12)
- PTPN20 (12)
- RNH1 (12)
- RTN4 (12)
- SEMA6D (12)
- SERPINA1 (12)
- TCF3 (12)
- TNIK (12)
- TP63 (12)
- TRPM3 (12)
- TTC23 (12)
- ZC3H14 (12)
- ABL2 (11)
- ARHGEF7 (11)
Species
Mutants
Mammalian Cell Selection
Families
- Druggable Genome (11346)
- Transmembrane (7495)
- Transcription Factors (2941)
- Secreted Protein (1926)
- Protein Kinase (887)
- Protease (704)
- ES Cell Differentiation/IPS (622)
- Stem cell - Pluripotency (520)
- GPCR (483)
- Phosphatase (311)
- Ion Channels: Other (231)
- Adult stem cells (138)
- Nuclear Hormone Receptor (127)
- Ion Channels: Potassium (125)
- Embryonic stem cells (121)
- Ion Channels: Cys-loop Receptors (73)
- P450 (73)
- Cancer stem cells (68)
- Induced pluripotent stem cells (66)
- Ion Channels: Transient receptor potential (48)
- Stem cell relevant signaling - JAK/STAT signaling pathway (42)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (38)
- Ion Channels: Glutamate Receptors (34)
- Stem cell relevant signaling - DSL/Notch pathway (27)
- Stem cell relevant signaling - Wnt Signaling pathway (26)
- Ion Channels: ATP Receptors (15)
- Ion Channels: Cyclic nucleotide gated (13)
- Ion Channels: Sodium (11)
Pathways
- Metabolic pathways (1744)
- Pathways in cancer (648)
- MAPK signaling pathway (514)
- Neuroactive ligand-receptor interaction (451)
- Cytokine-cytokine receptor interaction (435)
- Olfactory transduction (416)
- Regulation of actin cytoskeleton (390)
- Endocytosis (343)
- Focal adhesion (325)
- Chemokine signaling pathway (311)
- Calcium signaling pathway (305)
- Purine metabolism (294)
- Wnt signaling pathway (289)
- Huntington's disease (281)
- Neurotrophin signaling pathway (264)
- Alzheimer's disease (261)
- Ubiquitin mediated proteolysis (257)
- Jak-STAT signaling pathway (246)
- Axon guidance (239)
- Natural killer cell mediated cytotoxicity (236)
- Insulin signaling pathway (224)
- Cell adhesion molecules (CAMs) (223)
- Progesterone-mediated oocyte maturation (223)
- Tight junction (223)
- Cell cycle (222)
- Leukocyte transendothelial migration (218)
- Oocyte meiosis (206)
- Lysosome (205)
- T cell receptor signaling pathway (205)
- ErbB signaling pathway (193)
- Adherens junction (191)
- Fc gamma R-mediated phagocytosis (183)
- Prostate cancer (182)
- Toll-like receptor signaling pathway (181)
- Apoptosis (179)
- Hematopoietic cell lineage (178)
- Melanogenesis (177)
- Spliceosome (177)
- Vascular smooth muscle contraction (176)
- Oxidative phosphorylation (175)
- GnRH signaling pathway (173)
- Parkinson's disease (171)
- Dilated cardiomyopathy (170)
- Systemic lupus erythematosus (169)
- Colorectal cancer (162)
- Hypertrophic cardiomyopathy (HCM) (160)
- Pancreatic cancer (156)
- Pyrimidine metabolism (156)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (154)
- VEGF signaling pathway (154)
- Melanoma (147)
- B cell receptor signaling pathway (145)
- Gap junction (142)
- TGF-beta signaling pathway (142)
- PPAR signaling pathway (141)
- p53 signaling pathway (141)
- Chronic myeloid leukemia (140)
- Renal cell carcinoma (135)
- Small cell lung cancer (135)
- Antigen processing and presentation (132)
- Fc epsilon RI signaling pathway (130)
- Viral myocarditis (130)
- Acute myeloid leukemia (128)
- Complement and coagulation cascades (126)
- Glioma (125)
- RIG-I-like receptor signaling pathway (125)
- Adipocytokine signaling pathway (124)
- NOD-like receptor signaling pathway (123)
- Long-term potentiation (122)
- Phosphatidylinositol signaling system (121)
- Ribosome (120)
- Long-term depression (118)
- Epithelial cell signaling in Helicobacter pylori infection (115)
- Glycerophospholipid metabolism (115)
- Cardiac muscle contraction (111)
- Glycolysis / Gluconeogenesis (109)
- Endometrial cancer (108)
- Amyotrophic lateral sclerosis (ALS) (107)
- Drug metabolism - cytochrome P450 (107)
- ECM-receptor interaction (106)
- Metabolism of xenobiotics by cytochrome P450 (103)
- Pathogenic Escherichia coli infection (99)
- Non-small cell lung cancer (98)
- Vibrio cholerae infection (98)
- Basal cell carcinoma (97)
- mTOR signaling pathway (97)
- Bladder cancer (92)
- Cytosolic DNA-sensing pathway (89)
- Inositol phosphate metabolism (89)
- Drug metabolism - other enzymes (87)
- Retinol metabolism (86)
- Arginine and proline metabolism (85)
- Valine (85)
- Arachidonic acid metabolism (84)
- Hedgehog signaling pathway (84)
- Glutathione metabolism (83)
- Starch and sucrose metabolism (78)
- RNA degradation (77)
- Thyroid cancer (77)
- N-Glycan biosynthesis (76)
- Sphingolipid metabolism (73)
- Type II diabetes mellitus (73)
- Glycerolipid metabolism (72)
- Amino sugar and nucleotide sugar metabolism (71)
- Tyrosine metabolism (71)
- Fatty acid metabolism (70)
- leucine and isoleucine degradation (69)
- Autoimmune thyroid disease (67)
- Pyruvate metabolism (66)
- Lysine degradation (65)
- Cysteine and methionine metabolism (63)
- Primary immunodeficiency (63)
- Proteasome (63)
- Taste transduction (63)
- ABC transporters (62)
- Base excision repair (62)
- Nucleotide excision repair (61)
- Tryptophan metabolism (60)
- Type I diabetes mellitus (60)
- Notch signaling pathway (59)
- SNARE interactions in vesicular transport (59)
- Ether lipid metabolism (58)
- Alanine (56)
- aspartate and glutamate metabolism (56)
- Androgen and estrogen metabolism (55)
- Porphyrin and chlorophyll metabolism (55)
- Fructose and mannose metabolism (54)
- Graft-versus-host disease (54)
- Prion diseases (54)
- Aminoacyl-tRNA biosynthesis (53)
- Butanoate metabolism (52)
- Glycine (51)
- serine and threonine metabolism (51)
- Citrate cycle (TCA cycle) (50)
- Allograft rejection (48)
- Glycosphingolipid biosynthesis - lacto and neolacto series (48)
- Propanoate metabolism (48)
- Basal transcription factors (47)
- DNA replication (47)
- Galactose metabolism (46)
- Selenoamino acid metabolism (45)
- Pentose phosphate pathway (44)
- Nitrogen metabolism (43)
- Histidine metabolism (42)
- Glycosaminoglycan degradation (41)
- Homologous recombination (41)
- O-Glycan biosynthesis (41)
- Regulation of autophagy (41)
- Linoleic acid metabolism (40)
- Maturity onset diabetes of the young (39)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (38)
- Nicotinate and nicotinamide metabolism (38)
- Dorso-ventral axis formation (36)
- Mismatch repair (36)
- Phenylalanine metabolism (34)
- RNA polymerase (34)
- Asthma (33)
- Pentose and glucuronate interconversions (33)
- Heparan sulfate biosynthesis (32)
- Primary bile acid biosynthesis (32)
- beta-Alanine metabolism (32)
- Biosynthesis of unsaturated fatty acids (31)
- Keratan sulfate biosynthesis (31)
- Ascorbate and aldarate metabolism (30)
- Pantothenate and CoA biosynthesis (30)
- One carbon pool by folate (29)
- Renin-angiotensin system (29)
- Riboflavin metabolism (29)
- Chondroitin sulfate biosynthesis (28)
- Other glycan degradation (27)
- Sulfur metabolism (27)
- alpha-Linolenic acid metabolism (27)
- Steroid biosynthesis (25)
- Glycosphingolipid biosynthesis - globo series (24)
- Terpenoid backbone biosynthesis (24)
- Non-homologous end-joining (23)
- leucine and isoleucine biosynthesis (23)
- Glyoxylate and dicarboxylate metabolism (22)
- Glycosphingolipid biosynthesis - ganglio series (21)
- Cyanoamino acid metabolism (19)
- Limonene and pinene degradation (19)
- Taurine and hypotaurine metabolism (19)
- C21-Steroid hormone metabolism (18)
- Circadian rhythm - mammal (18)
- Folate biosynthesis (17)
- Caffeine metabolism (16)
- Synthesis and degradation of ketone bodies (14)
- Protein export (13)
- Thiamine metabolism (13)
- Fatty acid elongation in mitochondria (12)
- Methane metabolism (11)
- Ubiquinone and other terpenoid-quinone biosynthesis (10)
- Lipoic acid metabolism (7)
- O-Mannosyl glycan biosynthesis (7)
- Fatty acid biosynthesis (6)
- Phenylalanine (6)
- Vitamin B6 metabolism (6)
- tyrosine and tryptophan biosynthesis (6)
- Lysine biosynthesis (5)
- D-Glutamine and D-glutamate metabolism (4)
- Biotin metabolism (2)
- D-Arginine and D-ornithine metabolism (1)